# Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease

> **NCT00151918** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 48 (—)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Lanthanum carbonate

## Key facts

- **NCT ID:** NCT00151918
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01-07
- **Primary completion:** 2005-08-22
- **Final completion:** 2005-08-22
- **Target enrollment:** 48 (—)
- **Last updated:** 2021-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151918, "Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00151918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*